Kshitij Wagh, Ph.D.
Affiliations: | 2013 | Graduate School - New Brunswick | Rutgers University, New Brunswick, New Brunswick, NJ, United States |
Area:
General Biophysics, Genetics, Bioinformatics BiologyGoogle:
"Kshitij Wagh"Mean distance: (not calculated yet)
Parents
Sign in to add mentorGyan Bhanot | grad student | 2013 | Rutgers, New Brunswick | |
(Studies in viral population genetics and bioinformatics.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Lasrado N, Collier AY, Hachmann NP, et al. (2023) Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86. Vaccine |
Wagh K, Seaman MS. (2023) Divide and conquer: broadly neutralizing antibody combinations for improved HIV-1 viral coverage. Current Opinion in Hiv and Aids. 18: 164-170 |
Henderson R, Zhou Y, Stalls V, et al. (2023) Structural basis for breadth development in the HIV-1 V3-glycan targeting DH270 antibody clonal lineage. Nature Communications. 14: 2782 |
Haynes BF, Wiehe K, Borrow P, et al. (2023) Author Correction: Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies. Nature Reviews. Immunology |
Bibollet-Ruche F, Russell RM, Ding W, et al. (2023) A Germline-Targeting Chimpanzee SIV Envelope Glycoprotein Elicits a New Class of V2-Apex Directed Cross-Neutralizing Antibodies. Mbio. e0337022 |
Haynes BF, Wiehe K, Borrrow P, et al. (2022) Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies. Nature Reviews. Immunology |
Julg B, Stephenson KE, Wagh K, et al. (2022) Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial. Nature Medicine |
Mu Z, Wiehe K, Saunders KO, et al. (2022) mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice. Cell Reports. 38: 110514 |
Wagh K, van Gils MJ, Gristick H, et al. (2021) Editorial: Novel Concepts in Using Broadly Neutralizing Antibodies for HIV-1 Treatment and Prevention. Frontiers in Immunology. 12: 823576 |
Stephenson KE, Julg B, Tan CS, et al. (2021) Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial. Nature Medicine |